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ABSTRACT 
Background: Most girls with Turner syndrome (TS) are intensively followed by paediatricians, but 
are lost to follow-up when they reach adulthood. To gain insight into the adult medical and 
psychosocial situation, we performed a survey in young adult TS patients.  
Patients and Methods: A questionnaire concerning current health status, education, occupation 
and living situation was sent to 160 young adult TS women, all treated during childhood with GH 
and oestrogen if needed.  
Results: We received 102 completed questionnaires. Mean ± SD age at reception of the 
questionnaire was 23.4 ± 3.3 years, height 153.3 ± 5.2 cm, body mass index 23.7 ± 4.9 kg/ m². Age 
and auxological parameters were comparable between responders and non-responders. Thirteen 
(12.7%) responders were not under regular medical care; 15 (14.7%) were seen by a general 
practitioner, while 28 (27.4%) needed several specialists. Forty-one (40.2%) patients reported 
health problems. The most frequently reported problem was hypertension (10.7%), followed by 
hypothyroidism (5.8%) and back problems (4.9%). Twenty-four (23.5%) of the 41 patients were 
taking medication for the indicated health problems. Twenty-six (25.5%) women had undergone 
spontaneous puberty; 16 of them reported spontaneous menstruations while 10 received 
oestrogen replacement therapy. Of the 76 women with induced puberty, 11 (14.5%) were not 
taking any oestrogen anymore. Compared with the general population, more TS women attended 
university and more obtained higher education. Forty-six women (45.1%) were working full-time, 7 
(6.9%) were unemployed, and 4 (3.9%) received an allocation. Seventy (68.6%) patients were still 
living with their parents, while 18 (17.6%) were living together or married, and 14 (13.7%) were 
living alone.  
Conclusions: The transition of adolescents with TS to adult medical care is not optimal in Belgium. 
Although 40.2% of these young women reported health problems, 12.7% did not consult any 
physician. Many TS women did not take oestrogen replacement therapy. A specialized 
multidisciplinary approach for adults with TS is needed in order to optimize health and 
psychosocial status in these women. 
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Turner syndrome (TS) is a genetic disorder caused by the absence of or a structural abnormality of 
one X-chromosome, affecting approximately 1/2,000 females [1]. The phenotype is characterized 
by short stature, lack of pubertal development and infertility, and various dysmorphic features. 
Most of the patients are diagnosed during childhood [2] and received intensive medical follow-up 
by paediatric endocrinologists taking care of growth-promoting treatment with recombinant 
growth hormone (GH) and puberty induction with estrogens, if indicated [3]. Although it has been 
increasingly evident that adults with TS are susceptible to a large range of medical and 
psychosocial problems [2, 4], little is known about what happens to these patients after transition 
to adulthood, and many patients seem to “opt out” of the medical milieu when they reach 
adulthood [5]. Moreover, limited information is available on the long-lasting effect of GH treatment 
during childhood on health and psychosocial functioning of adult TS women. 
In order to gain insight into the actual medical care, health status, educational and occupational 
status, and psychosocial functioning of young adult TS women treated in Belgium, we sent a 
questionnaire to 160 young adult TS patients treated during childhood and adolescence with GH 
and oestrogens if needed to induce puberty. We report the results on the medical and psychosocial 
status of 102 women with TS who returned a filled out questionnaire. 
Patients and Methods  
PATIENTS  
In Belgium, most girls diagnosed with TS are followed by paediatric endocrinologists belonging to 
the Belgian Study Group for Paediatric Endocrinology (BSGPE). Patient data are stored in the 
BSGPE database. After completion of growth-promoting treatment and puberty induction, if 
needed, the patients are referred to an adult specialist, depending on the patients’ preferences, 
the contacts of the paediatric endocrinologist and the availability of a colleague familiar with TS 
patients. From the database of the BSGPE, containing the auxological data of nearly all GH-treated 
patients in Belgium since 1987, we retrieved all TS patients who had completed GH treatment for 
more than 1 year (n = 175). The auxological data have recently been published [3]. Patients were 
born between 1971 and 1985. Fifteen patients were excluded because permission from the ethical 
committee could not be obtained for one centre (5), because the treating physician was not 
working with the study group anymore (8), because of autosomal recessive gonadal dysgenesis 
with normal karyotype (1) or because the patient had deceased (1).  
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A questionnaire concerning current medical care, health status, education, occupation and living 
situation was mailed by the paediatric endocrinologist who had treated the patient during 
childhood, to the selected subjects. The study was approved by the local ethical committees of the 
participating centres. In total, 160 questionnaires were sent in autumn 2001. Data collection was 
closed in February 2002. Seven questionnaires came back undelivered (unknown address). After 3-
6 months, a reminder letter was sent to those patients who did not answer the first time. 102 filled 
out questionnaires were returned (response rate of 102/153 or 66%). The responders and non-
responders were compared for karyotype (including ring chromosome), adult height and weight at 
last paediatric visit, target height, age at start of GH treatment, years of GH treatment, years after 
stopping GH treatment, occurrence of spontaneous puberty and age at start of oestrogen 
treatment, if indicated. Concerning current medical care and health status, the patients were 
asked if they were regularly consulting a physician, if they had any current health problems and if 
they were taking any medication for these health problems. In addition, we asked the patient for 
her actual height and weight. Regarding education and occupation we asked whether the patient 
was actually studying, the type and level of study. The highest diploma obtained was determined. 
If special education had been followed, the type of this education was specified. For the 
responders who were not studying anymore, we asked whether they had a job, were searching for 
a job, stayed at home (housewife) or whether they received an allocation. In addition, we asked 
whether, according to the responder, the job they practised was lower than, equal to or higher 
than the education they received. Concerning the living situation, the patients were asked whether 
they were still living with their parents, with a partner or alone. In addition, we asked if they were 
single, married, or divorced. These data were compared to the general female Belgian population 
[6, 7].  
STATISTICS  
Results expressed as mean ± SD (range), absolute numbers or percentages. Responders and non-
responders were compared by non-paired t test. Comparisons between the studied TS women and 
the general female Belgian population were done by X2 test. A p value <0.05 was considered as 
significant. 
Results  
PATIENT CHARACTERISTICS  
A total of 102 filled out questionnaires were returned. Considering a prevalence of TS of 1/2,000 
newborn girls [1], this represents about 25% of the TS women born in the considered time interval 
(1971–1985). Table 1 shows the characteristics of the patients who responded to the questionnaire, 
compared to the non-responders. There were no differences between the groups for the evaluated 
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parameters. The age of the patients at the receipt of the questionnaire was 23.4 ± 3.3 years (16.9-
30.9 years). The reported height was 153.3 ± 5.2 cm (140-168 cm), which was comparable to the 
measured height (152.5 ± 5.6 cm) at the last visit in the paediatric clinic. The reported weight was 
55.9 ± 11.6 kg, also comparable with the last measured weight (54.2 B± 9.0 kg). Eleven patients 
(10.7%) were obese, defined as a body mass index 130 kg/m². Puberty was induced with ethinyl 
oestradiol in 76 patients (karyotypes: 45,X: n = 40; 45,X/46,Xi(Xq): n = 14; 46,Xi(Xq): n = 5; 45,X/46,XY: 
n = 4; 45,X/46,X(rX): n = 3; others: n = 3), whereas 26 patients (karyotypes: 45,X: n = 11; 45,X/46,XX: n 
= 4; 45,X/46,XY: n = 3; 45,X/ 46,Xi(Xq): n = 3; 46,Xi(Xq): n = 2; 46,XdelXp: n = 2; 45,X/47,XYY: n = 1) 
reported to have developed puberty spontaneously.  
Table 1. Characteristics of the responders and non-responders. 
 
Responders Non-responders 
Number of patients 102 58 
Karyotype (45,X/r(X)/other) 51/3/48 30/3/25 
Age at receipt, years 23.4±3.3 23.4±3.4 
Time since stop GH, years 6.4±2.8 6.6±2.7 
Age at last visit, years 18.2±1.6 18.2±2.3 
Measured height, cm 152.5±5.6  150.1±7.1 
Measured weight, kg 54.1±9.0 53.9±10.1 
Body mass index, kg/m2 23.7±4.9 23.8±3.9 
Target height, cm 161.4±5.7  161.8±5.7 
Age at start GH, years 11.6±2.9 11.9±3.2 
GH duration, years 5.3±2.4 4.9±2.4 
Age at start of ethinyl  
        oestradiol, years 14.5±1.9 14.7±2.0 
Induced/spontaneous puberty 76/26 51/7 
CURRENT MEDICAL CARE AND HEALTH STATUS  
Table 2 shows the various consulted physicians after transition to adulthood. Thirteen (12.7%) out 
of 102 patients did not have any follow-up by a physician. Sixty-two (60.7%) women visited only 
one physician: 15 (14.7%) the general practitioner, 18 (17.6%) the gynaecologist, 20 (19.6%) the 
adult endocrinologist and 8 (7.8%) the paediatric endocrinologist. Twenty-seven (26.4%) patients 
visited several specialists, including the gynaecologist, the paediatric endocrinologist or the adult 
endocrinologist. Eight patients (7.8%) visited the general practitioner and another specialist. Other 
consulted specialists were the cardiologist (2), ENT specialist (2), orthopaedic surgeon (2), 
dermatologist (2), urologist (1), pneumologist (1), neurologist (1) and psychiatrist (1). Forty-one 
(40.2%) of the responders reported one or more health problems, including hypertension (11 
patients), hypothyroidism (6), back problems (5), heart disease (3), migraine (3), asthma (2), knee 
problems (2), depression (2), epilepsy (2), scoliosis (2), overweight (2), diabetes mellitus (1), 
hearing problems (1), cholesteatoma (1). Interestingly, only 2 patients reported overweight as a 
health problem although 11 out of 102 subjects (10.7%) had a body mass index 130 kg/m². Three of 
the women reporting health problems did not visit a physician regularly, while 17 reported to visit 
several specialists. In contrast, 5 patients without reported health problems consulted several 
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physicians. Medication for these health problems was required in 24 patients (23.5%). Concerning 
oestrogen replacement therapy, 65 (85.5%) of the patients who had an induced puberty were still 
on oestrogen treatment, while 11 (14.5%) did not take any oestrogen anymore. Of the 26 patients 
with spontaneous puberty, 10 (38.5%) were taking oestrogen. All the women with spontaneous 
puberty without oestrogen treatment reported regular menstruations. From the women with 
health problems, 8 were not on oestrogen treatment, although they visited a physician regularly 
and 1 reported back problems. 
Table 2. Consulted physicians after transition of women with TS to adulthood. 





General practitioner 15 (14.7%) General practitioner + Gynaecologist 
+ Adult    
endocrinologist 




 Gynaecologist 18 (17.6%) Gynaecologist   i li  3 (3%) 








Adult endocrinologist + Gynaecologist 
+ Paediatric 
endocrinologist 





n = 13 (12.9%)  n = 62 (60.7%)   n = 27 (26.4%) 
EDUCATION AND OCCUPATION  
Figure 1 illustrates the education level of the TS women compared to that of the general female 
Belgian population. Forty-five women (44.1%) were still studying. Seven (6.8%) followed special 
education. Of the 95 women who did not follow special education, 1 patient received no education 
beyond primary school. Nine (9.5%) had only lower secondary education. The majority of the 
women (55/95; 57.9%) obtained the diploma of higher secondary education; 18 (18.9%) went on to 
higher education and 12 (12.7%) had attended university. Compared to the general female Belgian 
population [7], more TS women in our survey attended university (12.7 vs. 7.7%; p < 0.05) and more 
finished higher secondary education (57.9 vs. 41.1%; p < 0.05). Forty-six women (45.1%) were 
working full-time; 7 (6.8%) were unemployed and 4 (3.9%) were receiving state benefit. Fifteen 
women (14.7%) were working in health care as nurse (8), social assistant (2), geriatric helper (2), 
childcare worker (1), chemist’s assistant (1) or speech therapist (1). Another group of 13 responders 
(12.7%) were doing manual work (kitchen help, cleaning), 3 of them in a sheltered workplace. A 
third group of 15 women (14.7%) was working in administration as clerks (11), lawyer (2), translator 
(1), or administrator (1). One was working in education as a teacher. Two women did not specify 
their occupation. Of the working women, 44 indicated the level of their occupation: 35 (79.5%) 
found their job equal to their education, 1 (2.2%) found her job higher than her education, and 8 
(18.2%) were working below their education.  
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LIVING SITUATION  
Sixty-nine (67.6%) of the TS women were still living with their parents. Eighteen (17.6%) were living 
with a partner or were married, and 14 (13.7%) were living alone. One patient did not answer the 
question. Compared with the general Belgian female population in the same age range, 
significantly fewer TS women were married (7.9 vs. 42.6% respectively, p < 0.0001), and more of 
them were still living with their parents (68.3 vs. 38.9%; p < 0.0001). 











For patients with childhood-onset chronic disorders the transition from paediatric to adult-
oriented health care is a difficult period for patients and for caretakers [8]. Lack of communication 
between paediatric and adult care, and the absence of organized caring for adult patients with 
specific disorders might create clinical and practical problems during the transition period, 
expanding into adulthood. Paediatric care for TS patients is well centralized and coordinated by 
the paediatric endocrinologist, taking care of the various aspects of TS [9]. Adult care for patients 
with TS is less well organized and limited information is available. An American survey in 190 TS 
women showed that 50% had visited the endocrinologist, 17% the cardiologist and 44% another 
physician in the previous year [10]. In the UK, Poole and Leatherdale [11] reported that out of 30 
adult TS patients, 14 were followed in a general practise, 3 were still followed in a paediatric 
practise, 9 in a general endocrine clinic, 1 in a general medical clinic and 3 in a dedicated Adult 
Turner Clinic. Our survey reveals that in Belgium medical care for adult women with TS is 
inadequate: 12.7% of the women were not seeing any physician anymore, while 14.7% only 
consulted the general practitioner and 26.4% frequented several specialists. The 10 youngest 
patients were still taken care of by the paediatric endocrinologist; this may be due to their young 
age, the immaturity or lack of independence of some TS women [13], but this could also indicate 
difficulties in transitioning the TS women to adequate adult care. As our data only concern TS 
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women who were intensively followed during childhood, we do not have any data on the health 
status and medical care of TS women who did not receive this follow-up during childhood. Taken 
together, these data show that the transition to adult health care is suboptimal for most patients 
with TS. Adolescent TS patients should be informed about all aspects of adult TS life and the need 
for regular follow-up and preventive health care. In several countries, initiatives to centralize the 
care for adult TS patients based on local cooperation have been set up, e.g. in the UK, specialized 
and dedicated Adult Turner Clinics have been established throughout the country [4] and in 
Sweden a multidisciplinary approach has been developed [12]. 
Adults with TS are susceptible to a large range of medical disorders and psychosocial problems [3, 
4, 14]. Most important are the cardiovascular complications as hypertension, aortic dilatation and 
dissection, ischaemic heart disease and consequences of congenital cardiac anomalies [14-16]. In 
our study, 10.7% of the subjects reported to have hypertension. The most common endocrine 
complication in TS patients is hypothyroidism [17]. Of our patients, 5.8% reported to be 
hypothyroid. Some disorders, like the fertility problems, are important for personal life and might 
create problems in the life of a couple [2]. Also the high frequency of hearing problems [4, 14] has a 
major influence on social life. In our study, only 2 patients reported ear problems. Although we 
studied a relatively young population, this is a rather low number of patients. Maybe the patients 
do not consider this as a health problem, or they are not aware of the quality of their hearing. Many 
TS patients are confronted with obesity, increasing in the older population [18]. The discordance 
between the reported and observed number of patients with obesity in our study population 
suggests an underestimation of obesity related and maybe also of the other health problems. This 
may be due to the questionnaire method used, the young age of the patients, or to a tendency to 
minimize problems and to underestimate the impact as a defence mechanism. 
Although there is no doubt about the benefits of oestrogen treatment for adult TS patients, 
especially if ovarian failure is present, on metabolic aspects [19], uterine development [20], bone 
mineral density [21, 22] and cardiovascular risk factors [23, 24], many TS women stop their 
treatment at a relatively young age. In our survey, 14.5% of the subjects did not continue oestrogen 
treatment despite ovarian failure. Comparing this result with data from other studies is difficult 
since these reports are not limited to patients with previous GH treatment and they usually 
consider a larger age range. In the USA, Cunniff et al. [10] observed that 82% of the 190 responders 
were on oestrogen treatment and in Sweden, Landin-Wilhelmsen et al. [12] reported that 85% of 
the 283 women with TS were on oestrogen replacement therapy, with a variation of 64-100% 
between the different university hospitals. A Danish population study by Gravholt et al. [22] in 322 
adult TS patients showed that only 71% used hormone replacement therapy. In the UK, Conway et 
al. [18] observed that 22% of the patients had no oestrogen treatment at their first visit in the Adult 
Turner Clinic. Poole and Leatherdale [11] studied a small patient group more comparable to ours 
and reported that all 30 patients in their survey, with previous follow-up in a paediatric endocrine 
clinic, were on oestrogen treatment. Although our results are better than those from more 
historical surveys, probably as the result of intensive paediatric follow-up, still an important 
number of TS patients stop oestrogen treatment early. The indications of long-term sex hormone 
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replacement therapy have to be explained to adolescents with TS, and the advantages and 
disadvantages should be extensively discussed. 
In order to improve adult height young girls with TS are nowadays treated with supraphysiological 
doses of GH [3], which result in high serum IGF-I levels [25]. Our knowledge of the long-term effects 
of high-dose GH treatment is limited. Some studies reported a relationship between high IGF-I 
levels and an increased risk for breast cancer [26, 27] and colorectal cancer [28]. In addition, 
oestrogen replacement therapy might influence the breast cancer risk [29]. Moreover, the long-
term metabolic (e.g. insulin resistance) and cardiovascular repercussions of high-dose GH 
treatment and oestrogen replacement therapy are poorly defined [23]. This lack of knowledge 
together with the increasing number of patients treated urges a continued medical surveillance 
during adulthood. The complexity of the potential problems warrants the establishment of 
specialized Adult Turner Syndrome Clinics. 
The majority of TS patients have a normal intelligence, although verbal intelligence is mostly 
higher than the performal intelligence. Nevertheless, women with TS can achieve comparable 
levels of schooling as their family members and the majority enters or completes university or do 
postgraduate training [30]. Sybert [5] found that 33% of the adults with TS went to university, 
compared to 19% in the normal population and 10% had a postgraduate degree. Elsheikh et al. [4] 
reported that 35% of adult TS patients already obtained or were studying for a university degree in 
England. Our data confirm that also in Belgium, young TS women are at least as well educated as 
the general population, but they do not consider themselves to be overqualified for their job. 
However, many adults with TS have difficulties with respect to social functioning. Delooz et al. [31] 
described that the majority of the 20 examined patients had normal intelligence and were socially 
well adapted, but 50% expressed feelings of low self-confidence, depression and social insecurity, 
suggesting that achieving a mature level of psychosocial functioning remains a problem for many 
TS women. Downey et al. [13] compared 23 TS women with 23 women with constitutional short 
stature and found that TS women had a lower overall functioning on a global psychological health 
scale and had more impairment in social functioning. Data on the number of married TS women 
vary between 4 and 63%, depending on the number and age of the studied patients [5, 13, 32]. In 
our patients, only 18% was living with a partner or married. This is partly due to the large number 
of students in the studied population (44.1%) but nevertheless significantly more women were 
living with their parents, compared to the general female Belgian population of the same age. 
In summary, our data indicate that in Belgium the transition of adolescents with TS to adult 
medical care is not optimal. Once the TS woman is discharged from the paediatric clinic, there is 
still a long way to go, the major goal being to optimize the health and psychosocial wellbeing of 
these women. The transition period is important in this process. The adolescent patients should be 
informed about all aspects of adult TS life and the need for regular follow-up and preventive health 
care. A specialized multidisciplinary approach for the care of adult TS women should be 
recommended and established if possible. 
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